Skip to main content
Year archive

IMMUTEP LIMITED — 2019 filings

All 84 regulatory filings released by IMMUTEP LIMITED (IMM) in 2019, sourced directly from the official regulator.

84 Filings
2019 Period
2019 filings (84)
Filing Released Lang
INSIGHT-004 clinical trial update 3 pages 267.7KB
Regulatory Filings
2019-12-18 English
Change of Director's Interest Notice - Mr Voigt 3 pages 193.1KB
Director's Dealing
2019-12-08 English
Change of Director's Interest Notice - Dr Howard 2 pages 181.3KB
Director's Dealing
2019-12-08 English
Change of Director's Interest Notice - Mr Meyers 3 pages 190.0KB
Director's Dealing
2019-12-08 English
Appendix 3B 16 pages 519.9KB
Capital/Financing Update
2019-12-01 English
Immutep Investor Update 13 pages 2.6MB
Investor Presentation
2019-11-21 English
Immutep announces European patent grant for LAG525 antibody 2 pages 222.5KB
Regulatory Filings
2019-11-13 English
IMM presents positive interim phase 2 TACTI-002 data at SITC 3 pages 312.1KB
Interim / Quarterly Report
2019-11-07 English
2019 AGM Chairman's Address 3 pages 214.6KB
AGM Information
2019-10-31 English
2019 AGM CEO Presentation 24 pages 944.6KB
AGM Information
2019-10-31 English
Results of Annual General Meeting 2 pages 216.8KB
Declaration of Voting Results & Voting Rights Announcements
2019-10-31 English
Update - Consolidation/Split - IMM 4 pages 37.8KB
Share Issue/Capital Change
2019-10-31 English
Consolidation/Split - IMM 4 pages 37.7KB
Share Issue/Capital Change
2019-10-30 English
Operational Update 3 pages 303.6KB
Capital/Financing Update
2019-10-27 English
Change in substantial holding 6 pages 275.0KB
Regulatory Filings
2019-10-23 English
Appendix 4C - quarterly 5 pages 166.5KB
Interim / Quarterly Report
2019-10-22 English
Immutep presents positive TACTI-mel melanoma trial data 23 pages 2.6MB
Investor Presentation
2019-10-14 English
Immutep to present data at upcoming Industry Conferences 2 pages 232.1KB
Regulatory Filings
2019-10-09 English
Immutep receives A$2.5M R&D French Tax Incentive 2 pages 258.3KB
Capital/Financing Update
2019-10-09 English
Change of Director's Interest Notice - Mr Meyers 3 pages 190.1KB
Director's Dealing
2019-10-03 English
Change of Director's Interest Notice - Mr Chamberlain 3 pages 191.0KB
Director's Dealing
2019-10-03 English
Appendix 3B 15 pages 436.0KB
Share Issue/Capital Change
2019-10-02 English
Annual Report to shareholders 82 pages 1.2MB
Annual Report
2019-09-29 English
Appendix 4G & Corporate Governance Statement 32 pages 395.2KB
Governance Information
2019-09-29 English
Notice of Annual General Meeting/Proxy Form 31 pages 930.7KB
AGM Information
2019-09-29 English
Immutep Investor Presentation 39 pages 2.1MB
Investor Presentation
2019-09-29 English
Immutep expands Part A of TACTI-002 due to positive data 3 pages 265.7KB
Capital/Financing Update
2019-09-25 English
Annual Report filed on Form 20-F with SEC 199 pages 966.3KB
Annual Report
2019-09-23 English
Immutep to receive GBP4M Milestone Payment from GSK 2 pages 232.3KB
Capital/Financing Update
2019-09-22 English
Japanese patent granted for LAG525 antibody 2 pages 224.1KB
Regulatory Filings
2019-09-16 English
Immutep granted European patent for IMP321 in cancer 2 pages 222.5KB
Regulatory Filings
2019-08-21 English
Appendix 4E & 2019 Full Year Statutory Accounts 83 pages 1.3MB
Annual Report
2019-08-19 English
Change in substantial holding 5 pages 195.5KB
Regulatory Filings
2019-08-08 English
Change of Director's Interest Notice - Mr Voigt 2 pages 184.7KB
Director's Dealing
2019-08-06 English
Change of Director's Interest Notice - Mr Chamberlain 2 pages 189.4KB
Director's Dealing
2019-08-06 English
Immutep completes fully underwritten A$6M Entitlement Offer 2 pages 275.9KB
Capital/Financing Update
2019-08-05 English
Entitlement Offer Results & Shortfall Notification 2 pages 215.4KB
Capital/Financing Update
2019-07-31 English
Appendix 4C - quarterly 5 pages 184.4KB
Interim / Quarterly Report
2019-07-25 English
Operational Update 4 pages 308.7KB
Capital/Financing Update
2019-07-25 English
Change in substantial holding 6 pages 327.5KB
Regulatory Filings
2019-07-18 English
Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) 1
Capital/Financing Update
2019-07-16 English
Cleansing Notice 1 page 120.0KB
Capital/Financing Update
2019-07-16 English
Mailing of Offer Booklet for Entitlement Offer 1 pa
Capital/Financing Update
2019-07-16 English
Immutep raises A$10M via placement & entitlement offer 4 pages 351.3KB
Capital/Financing Update
2019-07-08 English
Immutep Capital Raising Presentation 27 pages 2.0MB
Capital/Financing Update
2019-07-08 English
Immutep Entitlement Offer Booklet 56 pages 2.3MB
Capital/Financing Update
2019-07-08 English
Appendix 3B 14 pages 394.8KB
Capital/Financing Update
2019-07-08 English
Letter to Eligible Shareholders 3 pages 194.2KB
Capital/Financing Update
2019-07-08 English
Letter to Ineligible Shareholders 2 pages 175.2KB
Capital/Financing Update
2019-07-08 English
Cleansing Notice 1 page 134.5KB
Capital/Financing Update
2019-07-08 English
Trading Halt 2 pages 415.2KB
Capital/Financing Update
2019-07-04 English
Immutep hosts Key Opinion Leader Call 2 pages 233.6KB
Call Transcript
2019-06-24 English
Immutep completes recruitment of AIPAC trial in MBC 3 pages 272.7KB
Regulatory Filings
2019-06-24 English
Immutep granted Australian patent for eftilagimod alpha 2 pages 176.2KB
Regulatory Filings
2019-06-20 English
Immutep completes recruitment of initial NSCLC cohort 2 pages 261.1KB
Capital/Financing Update
2019-06-12 English
First patient dosed in INSIGHT-004 3 pages 271.5KB
Capital/Financing Update
2019-06-05 English
Immutep Poster Presentation at ASCO 3 pages 260.5KB
Investor Presentation
2019-06-02 English
Appendix 3B 14 pages 553.5KB
Capital/Financing Update
2019-06-02 English
Immutep granted European patent for eftilagimod alpha 2 pages 222.1KB
Regulatory Filings
2019-05-22 English
More mature positive data for TACTI-mel trial presented 2 pages 229.5KB
Regulatory Filings
2019-05-16 English
Immutep to present at upcoming industry conferences 2 pages 233.2KB
Regulatory Filings
2019-05-09 English
Becoming a substantial holder 67 pages 2.9MB
Regulatory Filings
2019-05-07 English
Operational Update 4 pages 306.3KB
Investor Presentation
2019-04-29 English
Appendix 4C - quarterly 5 pages 184.1KB
Interim / Quarterly Report
2019-04-23 English
Webcast slides for eftilagimod alpha (IMP321) 29 pages 1.3MB
Investor Presentation
2019-04-01 English
Webcast details for update on eftilagimod alpha (IMP321) 2 pages 250.0KB
Investor Presentation
2019-03-26 English
Ceasing to be a substantial holder 10 pages 277.4KB
Regulatory Filings
2019-03-25 English
IMP761 Webcast Slides 13 pages 821.0KB
Investor Presentation
2019-03-24 English
Immutep granted US patent for IMP321 2 pages 176.9KB
Regulatory Filings
2019-03-21 English
Webcast to discuss IMP761 preclinical results 2 pages 212.6KB
Regulatory Filings
2019-03-18 English
IMP761 results presented at ECCO conference 2 pages 287.5KB
Regulatory Filings
2019-03-07 English
Immutep receives A$872,351 R&D Tax Incentive 1 page
Capital/Financing Update
2019-03-06 English
TACTI-mel data presented at World Immunotherapy Congress 3 pages 193.0KB
Regulatory Filings
2019-03-05 English
Immutep doses First Patient in TACTI-002 Phase II Trial 4 pages 250.3KB
Regulatory Filings
2019-03-05 English
Immutep to present at Oppenheimer Healthcare Conference 2 pages 149.9KB
Investor Presentation
2019-03-03 English
Half Year Accounts 29 pages 630.3KB
Regulatory Filings
2019-02-26 English
Immutep to present at upcoming industry conferences 2 pages 225.4KB
Investor Presentation
2019-02-25 English
Immutep Presentation to Emergence Conference 18 pages 1.1MB
Investor Presentation
2019-02-24 English
Immutep Investor Update 14 pages 1.1MB
Investor Presentation
2019-01-30 English
Appendix 4C - quarterly 5 pages 192.2KB
Interim / Quarterly Report
2019-01-23 English
Immutep enters into collaboration with CYTLIMIC 3 pages 145.0KB
Capital/Financing Update
2019-01-06 English
Change of Director's Interest Notice - Mr Voigt 4 pages 191.6KB
Director's Dealing
2019-01-03 English
Change of Director's Interest Notice - Dr Howard 3 pages 208.9KB
Director's Dealing
2019-01-03 English
Appendix 3B 15 pages 560.3KB
Share Issue/Capital Change
2019-01-01 English